Member Info for Laura2022

Seems qn over reaction given the plans to move forward

Do you thunk they'll make a move and what process moniman please

When is the jazz money due

Thanks

L

Funders are not going to keep giving £10-20mln a year to cash guzzling Co

They said this in December

Despite the ongoing challenges in the equity markets and broader economic landscape, post-period we were pleased to secure a £14.1 million (£13.6 million net) equity financing with existing institutional investors which extends our cash runway into Q3 2024 and will allow us to deliver multiple near-term value inflection points, in line with our refined strategic focus.

 

What they all have in common (SND C4XD REDX etc) is too much power to founders or IIs

This one Already has 84% acceptance

As at today's date, the Company has received letters of intent and irrevocable undertakings from certain Shareholders representing approximately 84.64 per cent. of the Company's issued share capital to vote in favour of the Resolutions.

 

They want /need £10mln according to the initial Sky reports last month

That's x 3 the market cap

Can't see it being pretty

Thanks Billy

You can essentially get the shares anyway at near to placing price regardless though?

Eg I bought at 10.1p

Anyone know how long the recent placing will last?

They say this in results

Our current projections are suggesting that this will be in the second half of next year. In the meantime, we will still need funds to bridge us to the point that we are cash generative

Company does not intend to make any further withdrawals pursuant to the Equity Prepayment Facility with RiverFort.

Thanks Ralph

Appreciate

Kudos to PYC for helping Ankara and other clients get drugs to this stage quicker and with more precision. Wonder if PYC could start to do more revenue sharing models with future contracts ?

Ankyra has conducted an exploratory study of JEN-101 in dogs with advanced melanoma. “The canine study has confirmed that JEN-101 elicits potent biological activity in dogs with melanoma at doses that demonstrate good safety,” stated Rob Tighe, Chief Scientific Officer at Ankyra. He added that “the canine trial provides preliminary evidence that JEN-101 offers a therapeutic benefit in dogs with cancer and adds to the validation of our anchored therapy platform as an effective way to reduce the toxicities associated with powerful anti-tumor agents, such as IL-12.”

Under the terms of the agreement, Jenga will have an exclusive worldwide license to develop, manufacture, and commercialize JEN-101. Ankyra will receive an upfront payment and Jenga will take the lead on further development and commercialization of JEN-101. Ankyra will be eligible for regulatory and commercial milestone payments, plus royalties on worldwide sales.

Thanks Ralph,is this also one for the PYC assets please ? ANK101

Ankyra Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Dose Escalation Cohort Evaluating ANK-101, an Anchored Immune Medicine, for Solid Tumors

Safety and tolerability to be determined at up to 10 study sites in the United States and Canada

March 05, 2024 08:00 AM Eastern Standard Time

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ankyra Therapeutics, a clinical stage biotechnology company pioneering anchored immunotherapies to treat cancer, today announced the first patient dosed in the dose escalation cohort in a Phase 1 clinical study evaluating ANK-101, a tumor-directed, anchored immune medicine for solid tumors

You can't negotiate from a position of strength when you have $600mln+ owed in debt but the market capitalisation is where it is

Unfortunately it feels like that UK Potash company (can't recall the name )

Unless I'm missing something and there is a positive outcome here ?

Totally agree taver

They treat the conapny as their personal play thing and vanity project

Then walk away into the sunset when it goes wrong

Totally agree LWHL

Then ones that are in trouble have had

1 overinflated BOD salaries

2 reckless spending

3 no grasp of debt

4 out dated business

In the bloodbath of AIM hugely indebted and bloated debt companies that make no effort to grow PYC is a breath of fresh air

Compared to HZM SND etc etc

Indie

I made 200% + on Cpx in similar

MEN could well do

Dave

You're a bore and hypocrit ..after your latest pump on TRAC 2 wesk ago

This will do a CPX style rise

Itsqgame etc - £500k cap!!

Pity one cannot buy at 5p!

Since I do understand the disappointment that this will cause and which I wholeheartedly share, whilst making no commitment to do so, I do not rule out in the fullness of time and subject to de-listing and on becoming a private company making proposals to buy the shares of certain of those holders who either do not wish or are unable to be invested in a private business.